SCARLETRED
Private Company
Total funding raised: $13M
Overview
SCARLETRED is a certified AI-MedTech company and a leader in standardized mobile skin imaging and analysis. Its core platform, Scarletred®Vision, is a medical device-certified system that uses a proprietary skin patch for calibration and AI to deliver objective, quantitative measurements of skin conditions, supporting numerous clinical scoring systems. The company serves pharmaceutical, cosmetic, and healthcare clients globally with a Software-as-a-Service (SaaS) model, aiming to accelerate clinical research and improve dermatological care.
Technology Platform
Scarletred®Vision: A certified mobile medical device system combining a proprietary calibration skin patch with a smartphone app for standardized 2D/3D/dermoscopic imaging. It uses AI for objective analysis, measuring lesion characteristics (size, color, texture) and automating clinical scores (PASI, EASI, etc.). Includes ARORA® AI for privacy compliance and skin type assessment.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
SCARLETRED competes in the digital dermatology and clinical trial endpoint market. Competitors include other specialized digital imaging/analysis startups, large CROs with in-house digital solutions, and generic telehealth platforms. Its key differentiators are its medical device certification, proprietary calibration technology for standardization, and direct integration with pharmaceutical endpoint scoring systems.